NuVasive (NUVA) Financials

$39.75

$0.00 (0.00%)

As on 08-Sep-2023 09:30EDT

Market cap

$2,085 Mln

Revenue (TTM)

$1,226 Mln

P/E Ratio

75

P/B Ratio

2.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	1,226.23	1,201.94	1,138.99	1,050.58	1,168.07	1,101.71
Cost of Revenue	347.50	336.51	322.28	321.63	312.36	311.16
Gross Profit	878.73	865.44	816.71	728.95	855.71	790.56
Operating Expenses	796.17	782.00	760.02	678.76	734.66	688.20
Operating Profit (EBIT)	82.43	64.77	31.39	34.81	117.05	102.35
Other Income	-7.62	-18.67	-25.30	-15.38	-4.01	-7.59
Profit before Tax	41.85	52.32	-58.38	-47.55	80.52	8.72
Provision for Tax	13.40	11.92	5.70	-10.39	15.28	-3.76
Profit after Tax (Net Income)	28.45	40.41	-64.09	-37.15	65.23	12.48
Minority Interest	--	--	--	--	--	--
Consolidated Profit	28.45	40.41	-64.09	-37.15	65.23	12.48

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	892.54	868.89	795.21	918.92	915.21	834.53
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	614.43	639.57	1,157.98	937.80	763.17	693.87
Current Liabilities	582.58	716.05	200.89	836.36	206.92	179.46
Total Liabilities	2,688.11	2,224.51	2,154.08	2,693.08	1,885.29	1,707.86

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	1,361.30	1,359.29	1,351.65	1,130.90	1,120.95	1,089.65
Current Assets	728.25	865.21	802.42	1,562.18	764.34	618.21
Total Assets	2,672.13	2,224.51	2,154.08	2,693.08	1,885.29	1,707.86
Total Debt*	906.15	1,006.08	1,006.44	1,531.04	702.02	602.53
Net Current Assets	145.68	149.16	601.53	725.82	557.42	438.75

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	169.12	182.17	185.91	235.29	219.18
Cash Flow from Investing Activities	--	-155.19	-136.07	-281.93	-134.48	-161.29
Cash from Financing Activities	--	-8.59	-653.35	736.66	-6.64	-14.58
Net Cash Inflow / Outflow	--	5.34	-610.78	643.84	94.29	42.04

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	0.47	0.64	-1.24	-0.72	1.19	0.24
Cash EPS ($)	--	2.99	1.65	2.00	3.68	2.71
Adjusted Book Value ($)	--	13.84	15.37	17.72	16.75	15.89
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	2.69	3.52	3.58	4.31	4.17
Free Cash Flow per Share ($)	--	0.47	1.35	1.47	1.92	2.09

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	2.20	-3.01	-1.83	4.27	0.89
ROE (%)	3.23	4.86	-7.48	-4.05	7.46	1.53
ROA (%)	1.03	1.85	-2.64	-1.62	3.63	0.75
EBIT Margin (%)	6.11	5.39	2.76	3.31	10.02	8.60
Net Margin (%)	2.33	3.41	-5.75	-3.59	5.60	1.14
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	4.44	0.06	0.08	-0.10	0.06	0.07
EBIT Growth (%)	152.84	106.33	-9.82	-70.26	23.51	-21.70
Net Profit Growth (%)	171.01	163.05	-72.49	-156.95	422.75	-84.97
EPS Growth (%)	155.45	1.52	-0.73	-1.60	4.03	-0.85
Book Value Growth (%)	6.18	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	75.00	64.06	-42.37	-78.64	64.78	208.62
Price / Book Value	2.62	2.98	3.41	3.18	4.62	3.12
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	19.40	15.79	19.20	19.48	18.66	13.74
Close Price ($)	41.59	41.24	52.48	56.33	77.34	49.56
High Price ($)	54.62	60.47	72.61	81.91	77.99	72.41
Low Price ($)	35.17	35.17	45.45	28.55	43.51	44.62
Market Cap ($ Cr)	2,084.86	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	0.50	1.16	1.27	1.67	0.77	0.72
Short term debt to equity ratio	0.40	0.53	0.01	0.71	0.01	--
Current Ratio	1.25	1.21	3.99	1.87	3.69	3.44
Quick Ratio	0.65	0.74	2.42	1.51	2.18	1.92
Interest Coverage	3.19	3.72	1.49	0.49	3.04	2.50

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	21.78	20.75	18.82	19.71	18.11	17.83
Asset Turnover	0.44	0.55	0.47	0.46	0.65	0.66
Receivable days	--	70.47	67.58	72.77	63.79	65.56
Inventory Days	--	355.17	349.33	348.09	342.42	305.48
Payable days	--	128.05	128.08	117.86	118.71	106.20
Cash Conversion Cycle	--	297.59	288.84	303.00	287.50	264.84

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.